Literature DB >> 6439032

Thrombotic and hemorrhagic complications in children with the lupus anticoagulant.

M L Bernstein, M Salusinsky-Sternbach, M Bellefleur, D W Esseltine.   

Abstract

Endogenous circulating anticoagulants are unusual in children without a congenital factor deficiency. In particular, the lupus anticoagulant has only rarely been reported in children. Despite its functioning in vitro to prolong the partial thromboplastin time, patients more frequently have problems with thrombosis than bleeding, unless there is a coexistent prothrombin deficiency or thrombocytopenia. We report the cases of three children with the lupus anticoagulant. Two children had associated thromboses. One had a thrombosis of the iliofemoral system and the other had a partial Budd-Chiari syndrome, a thrombosis of the deep calf veins and ureteric obstruction. The third child had a concomitant prothrombin deficiency and bleeding after tooth extraction. Associated findings in these patients included a positive antinuclear antibody test in two, a positive anti-DNA antibody test in two, a false-positive VDRL test in two, and an antiphospholipid antibody test in two.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6439032     DOI: 10.1001/archpedi.1984.02140500038014

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  11 in total

1.  Correction for age of anticardiolipin antibodies cut-off points.

Authors:  E Rapizzi; A Ruffatti; M Tonello; A Piccoli; A Calligaro; P Sfriso; S Todesco
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

Review 2.  Hepatic manifestations of autoimmune rheumatic diseases.

Authors:  S Abraham; S Begum; D Isenberg
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

Review 3.  The 'antiphospholipid syndrome' and the 'lupus anticoagulant'.

Authors:  J S Cameron; G Frampton
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

4.  Lupus anticoagulants in two children--bleeding due to nonphospholipid-dependent antiprothrombin antibodies.

Authors:  Karin Knobe; Ulf Tedgård; Torben Ek; Per-Erik Sandström; Andreas Hillarp
Journal:  Eur J Pediatr       Date:  2012-04-19       Impact factor: 3.183

5.  Thrombosis in systemic lupus erythematosus: a French collaborative study.

Authors:  M A Montes de Oca; M C Babron; O Blétry; M Broyer; V Courtecuisse; J L Fontaine; C Loirat; J P Méry; P Reinert; B Wechsler
Journal:  Arch Dis Child       Date:  1991-06       Impact factor: 3.791

6.  Steady improvement of prothrombin levels after cyclophosphamide therapy in pediatric lupus anticoagulant hypoprothrombinemia syndrome (LAHPS).

Authors:  Andrea Taddio; AnneMarie C Brescia; Loredana Lepore; Carlos D Rose'
Journal:  Clin Rheumatol       Date:  2007-05-22       Impact factor: 2.980

Review 7.  Transient antiphospholipid antibodies associated with acute infections in children: a report of three cases and a review of the literature.

Authors:  H Mizumoto; T Maihara; E Hiejima; M Shiota; A Hata; S Seto; T Atsumi; T Koike; D Hata
Journal:  Eur J Pediatr       Date:  2006-03-22       Impact factor: 3.183

8.  Splenic and renal infarction in systemic lupus erythematosus: association with anti-cardiolipin antibodies.

Authors:  M H Arnold; L Schrieber
Journal:  Clin Rheumatol       Date:  1988-09       Impact factor: 2.980

Review 9.  Antiphospholipid antibodies in paediatrics.

Authors:  A Ravelli; A Martini; G R Burgio
Journal:  Eur J Pediatr       Date:  1994-07       Impact factor: 3.183

10.  Lupus anticoagulant hypoprothrombinemia syndrome associated with systemic lupus erythematosus in children: report of two cases and systematic review of the literature.

Authors:  Rakesh Kumar Pilania; Deepti Suri; Ankur Kumar Jindal; Narender Kumar; Avinash Sharma; Praveen Sharma; Sandesh Guleria; Amit Rawat; Jasmina Ahluwalia; Surjit Singh
Journal:  Rheumatol Int       Date:  2018-08-11       Impact factor: 3.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.